Helping people live better
With tens of thousands of active users worldwide and proven clinical outcomes, DarioHealth is a global digital therapeutics solution leader revolutionizing the way people manage their chronic conditions. Built for and around the user, Dario has created individualized solutions that combine best practices in digital technologies, analytics, hardware, and personal coaching that gently instruct, encourage, and inspire users to self-manage their health day to day.
What Makes Dario Different?
At Dario, the user always comes first. From designing the medical devices and mobile applications to defining the communications and coaching, Dario’s goal is to create solutions that engage, inspire and motivate users to make Dario a part of their daily journey towards healthy living.
Every user is different. And every day is different. When self-monitoring a chronic condition, having accurate, personal information available in real-time is critical for adapting to the fluctuations of daily life.
Combination of Digital and Health Executives Drives Innovative Care Solutions
CEO, Board Member
President & GM US
Chief Commercial Officer
Omar Manejwala, M.D.
Chief Medical Officer
Chief Financial Officer
Chief Operational Officer
SVP Operations and Compliance
General Manager, Behavioral Health
General Manager, Musculoskeletal
VP HR & Chief of Staff
SVP, R&D and Delivery Solutions
SVP, Consumer Business Operations
VP, Clinical QA and RA
Who We Are And What We Stand For
These core values guide the way we work and the decisions we make each day
A User-First Approach
A personal approach with global reach
The world leading Dario Blood Glucose Monitoring System has US FDA clearance and approval
from the European CE, Health Canada, and Australia’s TGA.
Dario products are approved to sell in the United States, Canada, the United Kingdom, Germany, Italy, Australia, The Netherlands, and New Zealand. DarioHealth is rapidly moving into new geographic markets and chronic conditions including hypertension, stress management and obesity.